P2RX7 and status epilepticus: Results with P2X7 receptor antagonists in other models (Fischer et al., 2016; Smith et al., 2023) suggest it may also be relevant to explore whether dosing with JNJ-54175466 immediately after status epilepticus has anti-epileptogenic effects in the model.